Bellevue Life Sciences Acquisition Corp.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bellevue Life Sciences Acquisition Corp. generated cash of -$818,766, which is less than the previous year. Cash used in financing activities reached the amount of $34,539,499 last year. Net change in cash is therefore -$109,082.

Cash Flow

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC): Cash Flow
2020 -23.81K 0 86.46K
2021 -461 0 -57.43K
2022 -4.23K 0 123.97K
2023 -818.76K -33.82M 34.53M

BLAC Cash Flow Statement (2020 – 2023)

2023 2022 2021 2020
Cash at beginning of period
124.50K4.75K62.65K0
Operating activities
Net income
403.78K-35.38K-3.30K-23.81K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
0000
Stock-based compensation expense
0000
Deferred income tax benefit 0000
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
1.03M31.15K00
Cash generated by operating activities
-818.76K-4.23K-461-23.81K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
0000
Acquisitions Net
0000
Cash generated by investing activities
-33.82M000
Financing activities
Common Stock Issued
63.97M-683.02K-167.43K-213.53K
Payments for dividends
0000
Repurchases of common stock
-35.99M000
Repayments of term debt
-1.2M800K-110K-300K
Cash used in financing activities
34.53M123.97K-57.43K86.46K
Net Change In Cash
-109.08K119.74K-57.89K62.65K
Cash at end of period
15.41K124.50K4.75K62.65K
Data sourceData source